KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

New York Times (NYT) Research & Development (2019 - 2025)

Historic Research & Development for New York Times (NYT) over the last 7 years, with Q3 2025 value amounting to $67.0 million.

  • New York Times' Research & Development rose 976.41% to $67.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $259.2 million, marking a year-over-year increase of 593.96%. This contributed to the annual value of $248.2 million for FY2024, which is 847.63% up from last year.
  • As of Q3 2025, New York Times' Research & Development stood at $67.0 million, which was up 976.41% from $63.9 million recorded in Q2 2025.
  • In the past 5 years, New York Times' Research & Development registered a high of $67.0 million during Q3 2025, and its lowest value of $38.9 million during Q1 2021.
  • In the last 5 years, New York Times' Research & Development had a median value of $57.1 million in 2023 and averaged $54.7 million.
  • As far as peak fluctuations go, New York Times' Research & Development skyrocketed by 3333.65% in 2022, and later soared by 276.44% in 2025.
  • Quarter analysis of 5 years shows New York Times' Research & Development stood at $41.6 million in 2021, then soared by 33.34% to $55.5 million in 2022, then rose by 5.06% to $58.3 million in 2023, then increased by 6.01% to $61.8 million in 2024, then grew by 8.46% to $67.0 million in 2025.
  • Its Research & Development stands at $67.0 million for Q3 2025, versus $63.9 million for Q2 2025 and $66.5 million for Q1 2025.